Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study
Background Hypercobalaminemia is infrequently reported in companion animals and is considered of low clinical significance. Recent studies have described its association with inflammatory, immune‐mediated, endocrine, and neoplastic conditions in dogs and cats. Objectives We aimed to investigate the...
Gespeichert in:
Veröffentlicht in: | Veterinary clinical pathology 2023-12, Vol.52 (4), p.613-620 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 620 |
---|---|
container_issue | 4 |
container_start_page | 613 |
container_title | Veterinary clinical pathology |
container_volume | 52 |
creator | Henry, Perrine M. N. Williams, Tim L. |
description | Background
Hypercobalaminemia is infrequently reported in companion animals and is considered of low clinical significance. Recent studies have described its association with inflammatory, immune‐mediated, endocrine, and neoplastic conditions in dogs and cats.
Objectives
We aimed to investigate the association between hypercobalaminemia and neoplasia in companion animals and to identify other concurrent diseases or clinicopathologic changes.
Methods
This is a retrospective, case–control study. Medical records of patients with measured serum cobalamin concentration (2015‐2020) and no history of prior supplementation were reviewed. Hypocobalaminemic animals were excluded. Variables were compared between groups (hypercobalaminemic vs. normocobalaminemic) using non‐parametric statistics. Data are presented as median (range).
Results
Thirty‐five dogs and eight cats were hypercobalaminemic. At baseline, neoplasia was confirmed in 4/35 hypercobalaminemic dogs versus 11/70 control dogs (P = 0.77) and 0/8 hypercobalaminemic cats versus 3/16 control cats (P = 0.53). Cases without neoplasia at baseline were followed for 409 (13‐1854) days (dogs, n = 78) and 395 (28‐1670) days (cats, n = 21). During follow‐up, neoplasia was diagnosed in 4/27 hypercobalaminemic dogs versus 3/51 control dogs (P = 0.23) and 1/8 hypercobalaminemic cats versus 0/13 control cats (P = 0.38).
Pancreatitis was more frequent in hypercobalaminemic dogs (P = 0.006). Hypercobalaminemic dogs had higher serum total protein (P = 0.014), globulin (P = 0.001), and CRP (P = 0.032) concentrations and lower serum sodium (P = 0.012) and chloride (P = 0.033) concentrations than controls. Hypercobalaminemic cats had higher serum total protein concentrations than controls (P = 0.008).
Conclusion
Our results suggest that hypercobalaminemia is not associated with the presence or development of neoplasia in dogs and cats but may be associated with systemic inflammatory conditions, including pancreatitis, in dogs. |
doi_str_mv | 10.1111/vcp.13281 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2836874381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2836874381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3481-4e4e77838dac1ea0ed241b38f44e940136e8bc119e1edee060154324ad690293</originalsourceid><addsrcrecordid>eNp1kc9KJDEQh4O46Kx68AUk4MU9tKaSdHfamwzuuiCsBxFvIZPUaKT_mXSPzEX2HfYN90k22q4HwVwKqj4-UvUjZB_YMaR3srL9MQiuYIPMoBJVBkV-u0lmjJd5VgjFt8nXGB8YE3lqbZFtUUqhBIcZeb4KuDI1thZpt6Qtdn1tojfUtI7arrVjCNgO1PmIJmKkvqWuu4vT3AyRPvnhnt6vewy2W5jaNL7FxptTekYDDqGLPdrBrzDREf_-_pOkqVvTOIxuvUu-LE0dce-t7pDr7-fX84vs8tePn_Ozy8wKqSCTKLEslVDOWEDD0HEJC6GWUmIlGYgC1cICVAjoEFnBIJeCS-OKivFK7JCjSduH7nHEOOjGR4t1bdLCY9RciUK93AQSevgBfejG0KbPaV6xopR5zstEfZsomxaMAZe6D74xYa2B6ZdMdMpEv2aS2IM347ho0L2T_0NIwMkEPPka15-b9M38alL-A1SCmAc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906745527</pqid></control><display><type>article</type><title>Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study</title><source>Access via Wiley Online Library</source><creator>Henry, Perrine M. N. ; Williams, Tim L.</creator><creatorcontrib>Henry, Perrine M. N. ; Williams, Tim L.</creatorcontrib><description>Background
Hypercobalaminemia is infrequently reported in companion animals and is considered of low clinical significance. Recent studies have described its association with inflammatory, immune‐mediated, endocrine, and neoplastic conditions in dogs and cats.
Objectives
We aimed to investigate the association between hypercobalaminemia and neoplasia in companion animals and to identify other concurrent diseases or clinicopathologic changes.
Methods
This is a retrospective, case–control study. Medical records of patients with measured serum cobalamin concentration (2015‐2020) and no history of prior supplementation were reviewed. Hypocobalaminemic animals were excluded. Variables were compared between groups (hypercobalaminemic vs. normocobalaminemic) using non‐parametric statistics. Data are presented as median (range).
Results
Thirty‐five dogs and eight cats were hypercobalaminemic. At baseline, neoplasia was confirmed in 4/35 hypercobalaminemic dogs versus 11/70 control dogs (P = 0.77) and 0/8 hypercobalaminemic cats versus 3/16 control cats (P = 0.53). Cases without neoplasia at baseline were followed for 409 (13‐1854) days (dogs, n = 78) and 395 (28‐1670) days (cats, n = 21). During follow‐up, neoplasia was diagnosed in 4/27 hypercobalaminemic dogs versus 3/51 control dogs (P = 0.23) and 1/8 hypercobalaminemic cats versus 0/13 control cats (P = 0.38).
Pancreatitis was more frequent in hypercobalaminemic dogs (P = 0.006). Hypercobalaminemic dogs had higher serum total protein (P = 0.014), globulin (P = 0.001), and CRP (P = 0.032) concentrations and lower serum sodium (P = 0.012) and chloride (P = 0.033) concentrations than controls. Hypercobalaminemic cats had higher serum total protein concentrations than controls (P = 0.008).
Conclusion
Our results suggest that hypercobalaminemia is not associated with the presence or development of neoplasia in dogs and cats but may be associated with systemic inflammatory conditions, including pancreatitis, in dogs.</description><identifier>ISSN: 0275-6382</identifier><identifier>EISSN: 1939-165X</identifier><identifier>DOI: 10.1111/vcp.13281</identifier><identifier>PMID: 37438321</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>cobalamin ; inflammation ; neoplasia ; Pancreatitis</subject><ispartof>Veterinary clinical pathology, 2023-12, Vol.52 (4), p.613-620</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC on behalf of the American Society for Veterinary Clinical Pathology.</rights><rights>2023 The Authors. Veterinary Clinical Pathology published by Wiley Periodicals LLC on behalf of the American Society for Veterinary Clinical Pathology.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3481-4e4e77838dac1ea0ed241b38f44e940136e8bc119e1edee060154324ad690293</cites><orcidid>0000-0003-1630-9080 ; 0000-0002-9775-8285</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fvcp.13281$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fvcp.13281$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37438321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Henry, Perrine M. N.</creatorcontrib><creatorcontrib>Williams, Tim L.</creatorcontrib><title>Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study</title><title>Veterinary clinical pathology</title><addtitle>Vet Clin Pathol</addtitle><description>Background
Hypercobalaminemia is infrequently reported in companion animals and is considered of low clinical significance. Recent studies have described its association with inflammatory, immune‐mediated, endocrine, and neoplastic conditions in dogs and cats.
Objectives
We aimed to investigate the association between hypercobalaminemia and neoplasia in companion animals and to identify other concurrent diseases or clinicopathologic changes.
Methods
This is a retrospective, case–control study. Medical records of patients with measured serum cobalamin concentration (2015‐2020) and no history of prior supplementation were reviewed. Hypocobalaminemic animals were excluded. Variables were compared between groups (hypercobalaminemic vs. normocobalaminemic) using non‐parametric statistics. Data are presented as median (range).
Results
Thirty‐five dogs and eight cats were hypercobalaminemic. At baseline, neoplasia was confirmed in 4/35 hypercobalaminemic dogs versus 11/70 control dogs (P = 0.77) and 0/8 hypercobalaminemic cats versus 3/16 control cats (P = 0.53). Cases without neoplasia at baseline were followed for 409 (13‐1854) days (dogs, n = 78) and 395 (28‐1670) days (cats, n = 21). During follow‐up, neoplasia was diagnosed in 4/27 hypercobalaminemic dogs versus 3/51 control dogs (P = 0.23) and 1/8 hypercobalaminemic cats versus 0/13 control cats (P = 0.38).
Pancreatitis was more frequent in hypercobalaminemic dogs (P = 0.006). Hypercobalaminemic dogs had higher serum total protein (P = 0.014), globulin (P = 0.001), and CRP (P = 0.032) concentrations and lower serum sodium (P = 0.012) and chloride (P = 0.033) concentrations than controls. Hypercobalaminemic cats had higher serum total protein concentrations than controls (P = 0.008).
Conclusion
Our results suggest that hypercobalaminemia is not associated with the presence or development of neoplasia in dogs and cats but may be associated with systemic inflammatory conditions, including pancreatitis, in dogs.</description><subject>cobalamin</subject><subject>inflammation</subject><subject>neoplasia</subject><subject>Pancreatitis</subject><issn>0275-6382</issn><issn>1939-165X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp1kc9KJDEQh4O46Kx68AUk4MU9tKaSdHfamwzuuiCsBxFvIZPUaKT_mXSPzEX2HfYN90k22q4HwVwKqj4-UvUjZB_YMaR3srL9MQiuYIPMoBJVBkV-u0lmjJd5VgjFt8nXGB8YE3lqbZFtUUqhBIcZeb4KuDI1thZpt6Qtdn1tojfUtI7arrVjCNgO1PmIJmKkvqWuu4vT3AyRPvnhnt6vewy2W5jaNL7FxptTekYDDqGLPdrBrzDREf_-_pOkqVvTOIxuvUu-LE0dce-t7pDr7-fX84vs8tePn_Ozy8wKqSCTKLEslVDOWEDD0HEJC6GWUmIlGYgC1cICVAjoEFnBIJeCS-OKivFK7JCjSduH7nHEOOjGR4t1bdLCY9RciUK93AQSevgBfejG0KbPaV6xopR5zstEfZsomxaMAZe6D74xYa2B6ZdMdMpEv2aS2IM347ho0L2T_0NIwMkEPPka15-b9M38alL-A1SCmAc</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Henry, Perrine M. N.</creator><creator>Williams, Tim L.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1630-9080</orcidid><orcidid>https://orcid.org/0000-0002-9775-8285</orcidid></search><sort><creationdate>202312</creationdate><title>Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study</title><author>Henry, Perrine M. N. ; Williams, Tim L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3481-4e4e77838dac1ea0ed241b38f44e940136e8bc119e1edee060154324ad690293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>cobalamin</topic><topic>inflammation</topic><topic>neoplasia</topic><topic>Pancreatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Henry, Perrine M. N.</creatorcontrib><creatorcontrib>Williams, Tim L.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henry, Perrine M. N.</au><au>Williams, Tim L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study</atitle><jtitle>Veterinary clinical pathology</jtitle><addtitle>Vet Clin Pathol</addtitle><date>2023-12</date><risdate>2023</risdate><volume>52</volume><issue>4</issue><spage>613</spage><epage>620</epage><pages>613-620</pages><issn>0275-6382</issn><eissn>1939-165X</eissn><abstract>Background
Hypercobalaminemia is infrequently reported in companion animals and is considered of low clinical significance. Recent studies have described its association with inflammatory, immune‐mediated, endocrine, and neoplastic conditions in dogs and cats.
Objectives
We aimed to investigate the association between hypercobalaminemia and neoplasia in companion animals and to identify other concurrent diseases or clinicopathologic changes.
Methods
This is a retrospective, case–control study. Medical records of patients with measured serum cobalamin concentration (2015‐2020) and no history of prior supplementation were reviewed. Hypocobalaminemic animals were excluded. Variables were compared between groups (hypercobalaminemic vs. normocobalaminemic) using non‐parametric statistics. Data are presented as median (range).
Results
Thirty‐five dogs and eight cats were hypercobalaminemic. At baseline, neoplasia was confirmed in 4/35 hypercobalaminemic dogs versus 11/70 control dogs (P = 0.77) and 0/8 hypercobalaminemic cats versus 3/16 control cats (P = 0.53). Cases without neoplasia at baseline were followed for 409 (13‐1854) days (dogs, n = 78) and 395 (28‐1670) days (cats, n = 21). During follow‐up, neoplasia was diagnosed in 4/27 hypercobalaminemic dogs versus 3/51 control dogs (P = 0.23) and 1/8 hypercobalaminemic cats versus 0/13 control cats (P = 0.38).
Pancreatitis was more frequent in hypercobalaminemic dogs (P = 0.006). Hypercobalaminemic dogs had higher serum total protein (P = 0.014), globulin (P = 0.001), and CRP (P = 0.032) concentrations and lower serum sodium (P = 0.012) and chloride (P = 0.033) concentrations than controls. Hypercobalaminemic cats had higher serum total protein concentrations than controls (P = 0.008).
Conclusion
Our results suggest that hypercobalaminemia is not associated with the presence or development of neoplasia in dogs and cats but may be associated with systemic inflammatory conditions, including pancreatitis, in dogs.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37438321</pmid><doi>10.1111/vcp.13281</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1630-9080</orcidid><orcidid>https://orcid.org/0000-0002-9775-8285</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0275-6382 |
ispartof | Veterinary clinical pathology, 2023-12, Vol.52 (4), p.613-620 |
issn | 0275-6382 1939-165X |
language | eng |
recordid | cdi_proquest_miscellaneous_2836874381 |
source | Access via Wiley Online Library |
subjects | cobalamin inflammation neoplasia Pancreatitis |
title | Prevalence of neoplasia and concurrent diseases in dogs and cats with hypercobalaminemia: A retrospective case–control study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A10%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20neoplasia%20and%20concurrent%20diseases%20in%20dogs%20and%20cats%20with%20hypercobalaminemia:%20A%20retrospective%20case%E2%80%93control%20study&rft.jtitle=Veterinary%20clinical%20pathology&rft.au=Henry,%20Perrine%20M.%20N.&rft.date=2023-12&rft.volume=52&rft.issue=4&rft.spage=613&rft.epage=620&rft.pages=613-620&rft.issn=0275-6382&rft.eissn=1939-165X&rft_id=info:doi/10.1111/vcp.13281&rft_dat=%3Cproquest_cross%3E2836874381%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906745527&rft_id=info:pmid/37438321&rfr_iscdi=true |